Evidence map›Paper›PMID 24376827›Full record

ArticlePloS one2013

Nitrosative/oxidative stress conditions regulate thioredoxin-interacting protein (TXNIP) expression and thioredoxin-1 (TRX-1) nuclear localization.

Fernando Toshio Ogata, Wagner Luiz Batista, Adriano Sartori, Tarsis Ferreira Gesteira, Hiroshi Masutani, Roberto Jun Arai, Junji Yodoi, Arnold Stern, Hugo Pequeno Monteiro

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 41 citations in OpenAlex.

  1. Loss of Peroxiredoxin 6 Drives Age-Related Klf9/NF-Antioxidants (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Members of theInternational journal of molecular sciences · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Fernando Toshio OgataDepartamento de Bioquímica/Biologia Molecular and Center for Cellular and Molecular Therapy - CTCMol - Universidade Federal de São Paulo, São Paulo, Brazil.
Wagner Luiz BatistaDepartamento de Ciências Biológicas, Universidade Federal de São Paulo, Campus Diadema, São Paulo, Brazil.
Adriano SartoriDepartamento de Bioquímica/Biologia Molecular and Center for Cellular and Molecular Therapy - CTCMol - Universidade Federal de São Paulo, São Paulo, Brazil.
Tarsis Ferreira GesteiraDepartamento de Bioquímica/Biologia Molecular and Center for Cellular and Molecular Therapy - CTCMol - Universidade Federal de São Paulo, São Paulo, Brazil.
Hiroshi MasutaniDepartment of Biological Responses, Kyoto University, Kyoto, Japan.
Roberto Jun AraiDepartment of Pharmacology, New York University School of Medicine, New York, New York, United States of America.
Junji YodoiDepartment of Biological Responses, Kyoto University, Kyoto, Japan.
Arnold SternDepartment of Pharmacology, New York University School of Medicine, New York, New York, United States of America.
Hugo Pequeno MonteiroDepartamento de Bioquímica/Biologia Molecular and Center for Cellular and Molecular Therapy - CTCMol - Universidade Federal de São Paulo, São Paulo, Brazil.
Kyoto University · JPNew York University · USUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thioredoxin (TRX-1) is a multifunctional protein that controls the redox status of other proteins. TRX-1 can be found in the extracellular milieu, cytoplasm and nucleus, and it has distinct functions in each environment. Previously, we studied the intracellular localization of TRX-1 and its relationship with the activation of the p21Ras-ERK1/2 MAP Kinases signaling pathway. In situations where this pathway was activated by stress conditions evoked by a nitrosothiol, S-nitroso-N-acetylpenicillamine (SNAP), TRX-1 accumulated in the nuclear compartment due to nitrosylation of p21Ras and activation of downstream ERK1/2 MAP kinases. Presently, we demonstrate that ERK1/2 MAP Kinases activation and spatial distribution within cells trigger TRX-1 nuclear translocation through down-regulation of the physiological inhibitor of TRX-1, Thioredoxin Interacting Protein (TXNIP). Once activated by the oxidants, SNAP and H₂O₂, the ERK1/2 MAP kinases migrate to the nucleus. This is correlated with down-regulation of TXNIP. In the presence of the MEK inhibitors (PD98059 or UO126), or in cells transfected with the Protein Enriched in Astrocytes (PEA-15), a cytoplasmic anchor of ERK1/2 MAP kinases, TRX-1 nuclear migration and TXNIP down-regulation are no longer observed in cells exposed to oxidants. On the other hand, over-expression of TXNIP abolishes nuclear migration of TRX-1 under nitrosative/oxidative stress conditions, whereas gene silencing of TXNIP facilitates nuclear migration even in the absence of stress conditions. Studies based on the TXNIP promoter support this regulation. In conclusion, changes in TRX-1 compartmentalization under nitrosative/oxidative stress conditions are dependent on the expression levels of TXNIP, which are regulated by cellular compartmentalization and activation of the ERK1/2 MAP kinases.

Indexed as

Analysis of VarianceBlotting, WesternCarrier ProteinsCatalaseCell NucleusDNA PrimersFluorescent Antibody Technique, IndirectGene Expression RegulationGenetic VectorsGlutathione PeroxidaseHeLa CellsHumansMicroscopy, ConfocalOxidative StressReal-Time Polymerase Chain ReactionRNA, Small InterferingCarrier ProteinsCatalaseDNA PrimersGlutathione PeroxidaseRNA, Small InterferingThioredoxinsTXNIP protein, humanTXN protein, human

Identifiers

PMID24376827
PMCPMC3869934
OpenAlexW2057767979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.